Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Ho Ji

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Inhalation Toxicology|February 4, 2010
Exposure assessment of carbon nanotube manufacturing workplacesJi Hyun Lee, Seung-Bok Lee, Gwi Nam Bae, et al.
Inhalation Toxicology|August 10, 2007
Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley ratsJun Ho Ji, Jae Hee Jung, Sang Soo Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|July 17, 2012
A prospective multicentre phase II study of cisplatin and weekly docetaxel as first-line treatment for recurrent or metastatic nasopharyngeal cancer (KCSG HN07-01)Jun Ho Ji, , Tak Yun, et al.
JTO Clinical and Research Reports|June 20, 2022
Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief ReportYuanbin Chen, Luis Paz-Ares, Niels Reinmuth, et al.
Inhalation Toxicology|April 30, 2008
Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticlesJae Hyuck Sung, Jun Ho Ji, Jin Uk Yoon, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2021
Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3)Se-Il Go, Sang-Cheol Lee, Woo Kyun Bae, et al.
International Journal of Clinical and Experimental Pathology|October 15, 2015
Differential expression of heat shock protein 90 isoforms in small cell lung cancerJi Hyun Lee, Kyung Woo Kang, Jeong-Eun Kim, et al.
Journal of Geriatric Oncology|January 26, 2017
A multi-center, open-label, randomized phase III trial of first-line chemotherapy with capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancerIn Gyu Hwang, Jun Ho Ji, Jung Hun Kang, et al.
Japanese Journal of Clinical Oncology|January 29, 2015
Natural history of metastatic biliary tract cancer (BTC) patients with good performance status (PS) who were treated with only best supportive care (BSC)Jun Ho Ji, Haa-Na Song, Rock Bum Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|September 22, 2020
Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase III studyJonathan W Goldman, Marina Chiara Garassino, Yuanbin Chen, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Inhalation Toxicology|February 4, 2010
Exposure assessment of carbon nanotube manufacturing workplacesJi Hyun Lee, Seung-Bok Lee, Gwi Nam Bae, et al.
Inhalation Toxicology|August 10, 2007
Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley ratsJun Ho Ji, Jae Hee Jung, Sang Soo Kim, et al.
European Journal of Cancer (Oxford, England : 1990)|July 17, 2012
A prospective multicentre phase II study of cisplatin and weekly docetaxel as first-line treatment for recurrent or metastatic nasopharyngeal cancer (KCSG HN07-01)Jun Ho Ji, , Tak Yun, et al.
JTO Clinical and Research Reports|June 20, 2022
Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief ReportYuanbin Chen, Luis Paz-Ares, Niels Reinmuth, et al.
Inhalation Toxicology|April 30, 2008
Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticlesJae Hyuck Sung, Jun Ho Ji, Jin Uk Yoon, et al.
European Journal of Cancer (Oxford, England : 1990)|August 31, 2021
Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3)Se-Il Go, Sang-Cheol Lee, Woo Kyun Bae, et al.
International Journal of Clinical and Experimental Pathology|October 15, 2015
Differential expression of heat shock protein 90 isoforms in small cell lung cancerJi Hyun Lee, Kyung Woo Kang, Jeong-Eun Kim, et al.
Journal of Geriatric Oncology|January 26, 2017
A multi-center, open-label, randomized phase III trial of first-line chemotherapy with capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancerIn Gyu Hwang, Jun Ho Ji, Jung Hun Kang, et al.
Japanese Journal of Clinical Oncology|January 29, 2015
Natural history of metastatic biliary tract cancer (BTC) patients with good performance status (PS) who were treated with only best supportive care (BSC)Jun Ho Ji, Haa-Na Song, Rock Bum Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|September 22, 2020
Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase III studyJonathan W Goldman, Marina Chiara Garassino, Yuanbin Chen, et al.
Pageof 7